Order Article Reprints

Lee C-J, Modave E, Boeckx B, Stacchiotti S, Rutkowski P, Blay J-Y, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, et al. Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 “CREATE” Trial. Cancers. 2021; 13(23):6057. https://doi.org/10.3390/cancers13236057

Lee, Che-Jui, Elodie Modave, Bram Boeckx, Silvia Stacchiotti, Piotr Rutkowski, Jean-Yves Blay, Maria Debiec-Rychter, Raf Sciot, Diether Lambrechts, Agnieszka Wozniak, and et al. 2021. "Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 “CREATE” Trial" Cancers 13, no. 23: 6057. https://doi.org/10.3390/cancers13236057

Lee, C.-J., Modave, E., Boeckx, B., Stacchiotti, S., Rutkowski, P., Blay, J.-Y., Debiec-Rychter, M., Sciot, R., Lambrechts, D., Wozniak, A., & Schöffski, P. (2021). Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 “CREATE” Trial. Cancers, 13(23), 6057. https://doi.org/10.3390/cancers13236057